Literature DB >> 24317352

Plasma first in the field for postinjury hemorrhagic shock.

Ernest E Moore1, Theresa L Chin, Michael C Chapman, Eduardo Gonzalez, Hunter B Moore, Christopher C Silliman, Kirk C Hansen, Angela Sauaia, Anirban Banerjee.   

Abstract

Hemorrhage is the most preventable cause of death in civilian and military trauma, and despite tremendous advances in patient transport in the field, survival within the first hour has changed little over the past 40 years. The pathogenesis of trauma-induced coagulopathy is multifactorial, but most authorities believe there is an early depletion of clotting factors. While fresh frozen plasma delivered early in the emergency department has been shown to be beneficial, the rapid onset of trauma-induced coagulopathy suggests advancing this concept to the scene may improve patient outcome. The purpose of this report was to describe the rationale and design of a randomized trial to test the hypothesis that prehospital "plasma-first" resuscitation will benefit the critically injured patient. The rationale includes the possibility that plasma-first resuscitation may be advantageous beyond direct effects on clotting capacity. The study design is based on a ground ambulance system that allows rapid prehospital thawing of frozen plasma.

Entities:  

Mesh:

Year:  2014        PMID: 24317352      PMCID: PMC4004607          DOI: 10.1097/SHK.0000000000000110

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  28 in total

1.  Proteomic analysis of human mesenteric lymph.

Authors:  Monika Dzieciatkowska; Max V Wohlauer; Ernest E Moore; Sagar Damle; Erik Peltz; Jeffrey Campsen; Marguerite Kelher; Christopher Silliman; Anirban Banerjee; Kirk C Hansen
Journal:  Shock       Date:  2011-04       Impact factor: 3.454

2.  Proteomic analyses of human plasma: Venus versus Mars.

Authors:  Christopher C Silliman; Monika Dzieciatkowska; Ernest E Moore; Marguerite R Kelher; Anirban Banerjee; Xiayuan Liang; Kevin J Land; Kirk C Hansen
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

3.  The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service.

Authors:  Anne Sailliol; Christophe Martinaud; Andrew P Cap; Corinne Civadier; Benoit Clavier; Anne-Virginie Deshayes; Anne-Christine Mendes; Thomas Pouget; Nicolas Demazeau; Marine Chueca; François-Régis Martelet; Sylvain Ausset
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

4.  Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.

Authors:  Sisse R Ostrowski; Pär I Johansson
Journal:  J Trauma Acute Care Surg       Date:  2012-07       Impact factor: 3.313

5.  Evolution of a multidisciplinary clinical pathway for the management of unstable patients with pelvic fractures.

Authors:  W L Biffl; W R Smith; E E Moore; R J Gonzalez; S J Morgan; T Hennessey; P J Offner; C E Ray; R J Franciose; J M Burch
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

6.  Emergency use of prethawed Group A plasma in trauma patients.

Authors:  Martin D Zielinski; Pamela M Johnson; Donald Jenkins; Naeem Goussous; James R Stubbs
Journal:  J Trauma Acute Care Surg       Date:  2013-01       Impact factor: 3.313

7.  Early coagulopathy in trauma patients: an on-scene and hospital admission study.

Authors:  Bernard Floccard; Lucia Rugeri; Alexandre Faure; Marc Saint Denis; Eileen Mary Boyle; Olivier Peguet; Albrice Levrat; Christian Guillaume; Guillaume Marcotte; Alexandre Vulliez; Etienne Hautin; Jean Stéphane David; Claude Négrier; Bernard Allaouchiche
Journal:  Injury       Date:  2010-11-26       Impact factor: 2.586

8.  A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients.

Authors:  Pär I Johansson; Jakob Stensballe; Lars S Rasmussen; Sisse R Ostrowski
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

Review 9.  A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile.

Authors:  Anna M Ledgerwood; Charles E Lucas
Journal:  J Trauma       Date:  2003-05

10.  Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults.

Authors:  Guang Jin; Marc A DeMoya; Michael Duggan; Thomas Knightly; Ali Y Mejaddam; John Hwabejire; Jennifer Lu; William Michael Smith; Georgios Kasotakis; George C Velmahos; Simona Socrate; Hasan B Alam
Journal:  Shock       Date:  2012-07       Impact factor: 3.454

View more
  24 in total

1.  Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

2.  Pre-trauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients.

Authors:  Joshua B Brown; Jason L Sperry; Anisleidy Fombona; Timothy R Billiar; Andrew B Peitzman; Francis X Guyette
Journal:  J Am Coll Surg       Date:  2015-01-24       Impact factor: 6.113

3.  Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials.

Authors:  Anthony E Pusateri; Ernest E Moore; Hunter B Moore; Tuan D Le; Francis X Guyette; Michael P Chapman; Angela Sauaia; Arsen Ghasabyan; James Chandler; Kevin McVaney; Joshua B Brown; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; William R Witham; A Tyler Putnam; Jason L Sperry
Journal:  JAMA Surg       Date:  2020-02-19       Impact factor: 14.766

Review 4.  Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research.

Authors:  E Gonzalez; E E Moore; H B Moore; M P Chapman; C C Silliman; A Banerjee
Journal:  Scand J Surg       Date:  2014-04-30       Impact factor: 2.360

Review 5.  Optimal Fluid Therapy for Traumatic Hemorrhagic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

6.  Pretrauma center red blood cell transfusion is associated with reduced mortality and coagulopathy in severely injured patients with blunt trauma.

Authors:  Joshua B Brown; Mitchell J Cohen; Joseph P Minei; Ronald V Maier; Michaela A West; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore; Joseph Cuschieri; Jason L Sperry
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

7.  Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock.

Authors:  Hunter B Moore; Matthew T Tessmer; Ernest E Moore; Jason L Sperry; Mitchell J Cohen; Michael P Chapman; Anthony E Pusateri; Francis X Guyette; Joshua B Brown; Matthew D Neal; Brian Zuckerbraun; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2020-05       Impact factor: 3.313

8.  Plasma First Resuscitation Reduces Lactate Acidosis, Enhances Redox Homeostasis, Amino Acid and Purine Catabolism in a Rat Model of Profound Hemorrhagic Shock.

Authors:  Angelo D'Alessandro; Hunter B Moore; Ernest E Moore; Matthew J Wither; Travis Nemkov; Alexander P Morton; Eduardo Gonzalez; Michael P Chapman; Miguel Fragoso; Anne Slaughter; Angela Sauaia; Christopher C Silliman; Kirk C Hansen; Anirban Banerjee
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

9.  Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial.

Authors:  Hunter B Moore; Ernest E Moore; Michael P Chapman; Kevin McVaney; Gary Bryskiewicz; Robert Blechar; Theresa Chin; Clay Cothren Burlew; Fredric Pieracci; F Bernadette West; Courtney D Fleming; Arsen Ghasabyan; James Chandler; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

10.  Fibrinogen Protects Against Barrier Dysfunction Through Maintaining Cell Surface Syndecan-1 In Vitro.

Authors:  Feng Wu; Rosemary A Kozar
Journal:  Shock       Date:  2019-06       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.